Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

EPA:BON - FR0000063935 - Common Stock

7.64 EUR
-0.06 (-0.78%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

BON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 57 industry peers in the Food Products industry. BON has a bad profitability rating. Also its financial health evaluation is rather negative. BON has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BON has reported negative net income.
In the past year BON had a positive cash flow from operations.
BON had positive earnings in 4 of the past 5 years.
Of the past 5 years BON 4 years had a positive operating cash flow.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

BON has a Return On Assets of -6.06%. This is amonst the worse of the industry: BON underperforms 82.46% of its industry peers.
The Return On Equity of BON (-21.14%) is worse than 82.46% of its industry peers.
BON's Return On Invested Capital of 5.16% is in line compared to the rest of the industry. BON outperforms 49.12% of its industry peers.
BON had an Average Return On Invested Capital over the past 3 years of 3.87%. This is below the industry average of 7.09%.
The 3 year average ROIC (3.87%) for BON is below the current ROIC(5.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Operating Margin, with a value of 3.73%, BON is in line with its industry, outperforming 43.86% of the companies in the same industry.
In the last couple of years the Operating Margin of BON has declined.
BON has a worse Gross Margin (28.41%) than 73.68% of its industry peers.
BON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

BON has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BON has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BON remains at a similar level compared to 5 years ago.
BON has a worse debt/assets ratio than last year.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.90 indicates that BON is not a great score, but indicates only limited risk for bankruptcy at the moment.
BON has a Altman-Z score (1.90) which is in line with its industry peers.
A Debt/Equity ratio of 0.88 indicates that BON is somewhat dependend on debt financing.
BON has a Debt to Equity ratio of 0.88. This is in the lower half of the industry: BON underperforms 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.9
ROIC/WACC1.02
WACC5.05%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.33 indicates that BON should not have too much problems paying its short term obligations.
BON's Current ratio of 1.33 is in line compared to the rest of the industry. BON outperforms 49.12% of its industry peers.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
BON has a Quick ratio of 0.43. This is amonst the worse of the industry: BON underperforms 80.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -8526.77% in the last year.
The Revenue has decreased by -1.04% in the past year.
BON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.11% yearly.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

BON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.53% yearly.
Based on estimates for the next years, BON will show a small growth in Revenue. The Revenue will grow by 2.07% on average per year.
EPS Next Y-15.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
EPS Next 5Y19.53%
Revenue Next Year-7.88%
Revenue Next 2Y-3.4%
Revenue Next 3Y-1.47%
Revenue Next 5Y2.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BON. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 5.85, the valuation of BON can be described as very cheap.
Based on the Price/Forward Earnings ratio, BON is valued cheaply inside the industry as 96.49% of the companies are valued more expensively.
BON's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE N/A
Fwd PE 5.85
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

96.49% of the companies in the same industry are more expensive than BON, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.13
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BON's earnings are expected to grow with 21.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.13%
EPS Next 3Y21.03%

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.51%.
Compared to an average industry Dividend Yield of 3.27, BON has a dividend in line with its industry peers.
BON's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of BON are negative and hence is the payout ratio. BON will probably not be able to sustain this dividend level.
DP-6.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

BONDUELLE SCA

EPA:BON (9/5/2025, 7:00:00 PM)

7.64

-0.06 (-0.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-06 2025-05-06
Earnings (Next)09-26 2025-09-26/amc
Inst Owners7.04%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap249.29M
Analysts73.33
Price Target8.93 (16.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.38%
PT rev (3m)0.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.45%
EPS NY rev (3m)-14.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-1.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.85
P/S 0.11
P/FCF N/A
P/OCF 3.63
P/B 0.41
P/tB 0.77
EV/EBITDA 3.13
EPS(TTM)-4.03
EYN/A
EPS(NY)1.31
Fwd EY17.11%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY27.57%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.9
F-Score4
WACC5.05%
ROIC/WACC1.02
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y-15.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
EPS Next 5Y19.53%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-7.88%
Revenue Next 2Y-3.4%
Revenue Next 3Y-1.47%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1309.91%
EBIT Next 3Y146.14%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A